St-Pierre, Joëlle
Klein, Jeremy
Choi, Natalie K.
Fear, Evan
Pannain, Silvana
Rubin, David T.
Article History
Received: 15 July 2024
Accepted: 25 October 2024
First Online: 8 November 2024
Declarations
:
: SP: SP has served as a consultant for Noro Nordisk and Lilly, she receives research support from Amgen and Novo Nordisk, she is in the Speaker’s Bureau for Novo Nordisk and Lilly. JSP, JK, NKC, EF: No conflicts of interest to disclose.
: This study was reviewed and approved by the Institutional Review Board (IRB, Ethics Board) at the University of Chicago. Each subject provided informed consent (IRB protocol 15573A).